(19)
(11) EP 1 838 325 A1

(12)

(43) Date of publication:
03.10.2007 Bulletin 2007/40

(21) Application number: 06700349.1

(22) Date of filing: 04.01.2006
(51) International Patent Classification (IPC): 
A61K 31/554(2006.01)
A61P 25/20(2006.01)
A61P 25/30(2006.01)
A61P 25/36(2006.01)
A61P 25/00(2006.01)
A61P 25/26(2006.01)
A61P 25/32(2006.01)
(86) International application number:
PCT/SE2006/000009
(87) International publication number:
WO 2006/073360 (13.07.2006 Gazette 2006/28)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

(30) Priority: 07.01.2005 US 642262 P
18.11.2005 US 737887 P
18.11.2005 US 737865 P
18.11.2005 US 737864 P

(71) Applicant: AstraZeneca AB
151 85 Södertälje (SE)

(72) Inventors:
  • DAVIS, Patricia C. AstraZeneca Wilmington
    Wilmington, DE 19850-5437 (US)
  • GOLDSTEIN, Jeffrey M. AstraZeneca Wilmington
    Wilmington, DE 19850-5437 (US)
  • GRIMM, Scott W. AstraZeneca Wilmington
    Wilmington, DE 19850-5437 (US)
  • SUCKOW, Raymond F.
    West Patterson, NJ 07424 (US)
  • WINTER, Helen R. AstraZeneca Wilmington
    Wilmington, DE 19850-5437 (US)

(74) Representative: Bassil, Nicholas Charles et al
Kilburn & Strode 20 Red Lion Street
London WC1R 4PJ
London WC1R 4PJ (GB)

   


(54) NEW USE OF 11-PIPERAZIN-1-YLDIBENZO [b,f][1,4]THIAZEPINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT AND TO ORAL PHARMACEUTICAL COMPOSITIONS